Hidradenitis suppurativa (HS) is a relatively common skin disease, affecting as many as one percent of people worldwide. But ...

Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer's; on track to generate top-line data H1 2025 - - Recent third-party clinical data esta ...

The Zacks analyst believes that the planned launch of an in-house ad tech platform next year signals the ... Kisqali, Pluvicto Drive Novartis (NVS) Amid Competition Per the Zacks analyst, drugs like ...

Meta to Offer 'Less Personalized Ads' in Concession to EU The Facebook and Instagram ... Schrödinger enters collaboration pact with Novartis worth up to $2.5 billion Schrödinger will receive $150 ...

" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...

Regulators in the US and Europe have started to review Novartis' biosimilar version of ... and Crohn's disease in the US, ad highly-active RRMS in the EU. The looming competition piles further ...

The daylong leadership conference touched on numerous topics relevant to medical marketers, pharma executives and media ...

Schrödinger Inc.’s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the third quarter of 2024 and provided a business update. In a separate press release issued earlier ...

John Gustofson, MS, MBA appointed to the Board of Directors The appointment is in conjunction with Chugai Venture Fund joining syndicate with an investment that brings Hyku’s total seed financing to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...